How should your next vaccine dose change as COVID evolves? | Fast Company


When the omicron variant of COVID-19 emerged in South Africa late last year, it took only weeks to overtake delta, the variant that previously dominated. Then the original version of omicron was replaced by one subvariant, and then another. The latest subvariants, BA.4 and BA.5, are now quickly spreading in the U.S.

The virus is evolving so quickly that when Moderna recently announced preliminary results from the trial of its newest COVID-19 vaccine—the first designed to target both the original virus and omicron—the vaccine was already somewhat outdated since it wasn’t designed to stymie the newest subvariants. And when the Food and Drug Administration (FDA) meets at the end of June to discuss whether the vaccine should be modified before the likely rollout of more booster shots in the fall, it will have to make decisions without knowing how the virus will continue to change.

Read More

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s